Research
and development
The MatriceLab team continues its research and development work to combat infertility and support patients and couples in their life projects. As an independent laboratory for research and innovation, MatriceLab is developing an increasingly comprehensive and effective pathway for the dissemination of its first diagnostic test to as many people as possible in France and internationally.
The team is also working on the development of new diagnostic tests and procedures in the field of women’s health to further research efforts in reproductive immunology.
Our publications
Using endometrial immune profiling in young IVF patients: implantation rates improved for morphologically sub-optimal embryos
March 2026
Endometrial immune profiling: Bridging pre-eclampsia research with infertility solutions
Oct. 2025
Endometrial immune profiling and precision therapy increase live birth rate after embryo transfer: a randomised controlled trial
Feb. 2025
The Next Frontier in ART: Harnessing the Uterine Immune Profile for Improved Performance
July 2023
The Endometrial Immune Profiling May Positively Affect the Management Of Recurrent Pregnancy Loss
March 2021
Target Endometrial Scratching: An Example of Endometrial Diagnosis Usage in Reproductive Medicine.
Sept. 2020
Covid19- and immunomodulation treatment for women with reproductive failures
June 2020
Endometrial Immune Profiling : A method to design Personalized Care in Assisted Reproductive Medicine.
June 2020
Intralipids may represent a new hope for patients with reproductive failures and simltanously an over immune endometrial activation
Sept. 2018
Impact of prednisone in patients with repeated embryo implantation failures: Beneficial or deleterious?
March 2018
Uterine immune profiling for increasing live birth rate: A one-to-one matched cohort study
Nov. 2016
The Uterine Immune Profile May Help Women With Repeated Unexplained Embryo Implantation Failure After In Vitro Fertilization
Dec. 2015
2004 - 2011
New pre-conception immune biomarkers for clinical practice: interleukin-18, interleukin-15 and TWEAK on the endometrial side, G-CSF on the follicular side.
2011
TWEAK appears as a modulator of endometrial IL-18 related cytotoxic activity of uterine natural killers.
2011
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor inducible-14 might regulate the effects of interleukin 18 and 15 in the human endometrium.
2009
Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure.
2005
Materno-foetal dialogue and human embryo implantation: some evolving concepts
2004
A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization
2004